Ray Dalio Enovis Corp Transaction History
Bridgewater Associates, LP
- $18.9 Billion
- Q2 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Enovis Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 9,765 shares of ENOV stock, worth $386,498. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,765
Previous 9,957
1.93%
Holding current value
$386,498
Previous $621,000
28.99%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ENOV
# of Institutions
303Shares Held
60.1MCall Options Held
1.63MPut Options Held
576K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.64MShares$263 Million0.19% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$215 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$212 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.15MShares$125 Million0.04% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH2.79MShares$110 Million0.55% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.14B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...